AN2 Therapeutics

Verified by our team

  • Biotech
Linkedin Twitter Facebook

AN2 Therapeutics is a biopharmaceutical company focused on developing therapies for rare, chronic, and serious infectious diseases in areas with high unmet medical needs, leveraging expertise in infectious disease research and boron chemistry.

AN2 Therapeutics Highlights:

  • AN2 Therapeutics annual revenue is $7.9M.
  • AN2 Therapeutics total funding is $92.0M.
  • AN2 Therapeutics headquartered in Menlo Park, California.
  • AN2 Therapeutics number of employees is 51.

    • Overview

    • Website: an2therapeutics.com
    • Headquarters: Menlo Park, California
    • Employees: 51
    • Founded: 2019
    • Email: info@an2therapeutics.com
    • Funding: $92.0M
    • Revenue: $7.9M
    • Valuation: n/a

    Contacts

    Kevin O'Shea

    Director
    Linkedin
    • Email: ***@an2therapeutics.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to AN2 Therapeutics

    AN2 Therapeutics is located in Menlo Park, California.
    Yes, AN2 Therapeutics is a Silicon Valley company.
    AN2 Therapeutics total funding is 92.0M.
    AN2 Therapeutics revenue is 7.9M.
    AN2 Therapeutics’s number of employees is 51.
    AN2 Therapeutics’s CEO name is Kevin O’Shea.
    AN2 Therapeutics was founded in 2019.
    AN2 Therapeutics’s contact email is info@an2therapeutics.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ